HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Don J Diamond Selected Research

Vaccinia

11/2014Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.
2/2013A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.
1/2011Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model.
8/2010Intergenic region 3 of modified vaccinia ankara is a functional site for insert gene expression and allows for potent antigen-specific immune responses.
10/2008A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models.
6/2008Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques.
1/2007Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.
6/2006Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals.
4/2006In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
3/2006Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Don J Diamond Research Topics

Disease

20Infection
01/2016 - 09/2003
17Neoplasms (Cancer)
09/2015 - 11/2002
13Vaccinia
11/2014 - 04/2003
5Communicable Diseases (Infectious Diseases)
06/2014 - 11/2002
4Cytomegalovirus Infections (Inclusion Disease)
07/2015 - 02/2004
3Graft vs Host Disease (Graft-Versus-Host Disease)
05/2014 - 06/2009
3Brain Neoplasms (Brain Tumor)
10/2012 - 06/2005
2Leukemia
05/2014 - 08/2011
2Glioma (Gliomas)
10/2012 - 02/2011
2Melanoma (Melanoma, Malignant)
10/2012 - 06/2011
2Tetanus
04/2012 - 11/2002
2Carcinoma (Carcinomatosis)
01/2011 - 08/2004
2Viremia
03/2007 - 04/2006
1Hematologic Neoplasms (Hematological Malignancy)
11/2013
1Wilms Tumor (Wilm's Tumor)
11/2013
1Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2013
1Myeloid Leukemia (Leukemia, Myelocytic)
08/2011
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2011
1Human Influenza (Influenza)
04/2011
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2011
1Kidney Neoplasms (Kidney Cancer)
10/2007
1Cystitis
09/2007
1Progressive Multifocal Leukoencephalopathy
06/2006
1HIV Infections (HIV Infection)
05/2005
1Sarcoma (Soft Tissue Sarcoma)
08/2004
1Hypersensitivity (Allergy)
05/2002

Drug/Important Bio-Agent (IBA)

17AntigensIBA
07/2015 - 05/2002
6Neutralizing AntibodiesIBA
12/2015 - 04/2004
5EpitopesIBA
12/2015 - 11/2002
5VaccinesIBA
07/2015 - 11/2002
4Proteins (Proteins, Gene)IBA
02/2013 - 02/2004
4OligodeoxyribonucleotidesIBA
10/2012 - 08/2004
4HLA-A*0201 antigenIBA
04/2012 - 11/2002
3Glycoproteins (Glycoprotein)IBA
07/2015 - 04/2004
3DNA (Deoxyribonucleic Acid)IBA
04/2015 - 05/2005
3PeptidesIBA
11/2005 - 11/2002
2Interleukin-10 (Interleukin 10)IBA
01/2016 - 09/2011
2Serine Proteases (Serine Protease)IBA
09/2015 - 08/2011
2Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
09/2015 - 12/2012
2Small Interfering RNA (siRNA)IBA
12/2012 - 06/2011
2Toll-Like Receptors (Toll-Like Receptor)IBA
10/2012 - 07/2010
2Carbon Nanotubes (Carbon Nanotube)IBA
10/2012 - 02/2011
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
04/2012 - 08/2011
2InterferonsIBA
03/2007 - 09/2003
1erucylphosphocholineIBA
12/2015
1Hyaluronic Acid (Hyaluronan)IBA
09/2015
1AntibodiesIBA
11/2014
1Carbon MonoxideIBA
11/2014
1Codon (Codons)IBA
11/2014
1Histocompatibility Antigens (Histocompatibility Antigen)IBA
05/2014
1Toll-Like Receptor 9IBA
12/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2012
1Subunit VaccinesIBA
04/2012
1MVAp53 vaccineIBA
10/2011
1Myeloblastin (Proteinase 3)IBA
08/2011
1Leukocyte Elastase (Neutrophil Elastase)IBA
08/2011
1Immunoglobulin G (IgG)IBA
04/2011
1Immunoglobulin M (IgM)IBA
04/2011
1gemcitabineFDA Link
01/2011
1Intergenic DNA (Junk DNA)IBA
08/2010
1Combined VaccinesIBA
07/2010
1SteroidsIBA
06/2009
1Mamu-A 01 antigenIBA
04/2009
1KIR ReceptorsIBA
03/2009
1Cytomegalovirus VaccinesIBA
06/2008
1oblimersen (G3139)IBA
10/2007
1Interferon-alpha (Interferon Alfa)FDA Link
10/2007
1Amino AcidsFDA Link
06/2006
1HLA-A Antigens (HLA-A)IBA
09/2005
1Nuclear Proteins (Protein, Nuclear)IBA
06/2005
1Interferon-gamma (Interferon, gamma)IBA
02/2005
1Immunodominant EpitopesIBA
08/2004
1UbiquitinIBA
08/2004
1GuanineIBA
08/2004
1CPG-oligonucleotideIBA
08/2004
1CytosineIBA
08/2004
1Viral AntigensIBA
05/2004
1HLA-B*07IBA
04/2003

Therapy/Procedure

7Immunotherapy
10/2012 - 11/2002
6Transplants (Transplant)
05/2014 - 11/2005
3Cell Transplantation
07/2009 - 11/2002
3Transplantation (Transplant Recipients)
06/2009 - 03/2007
2Injections
11/2014 - 04/2012
2Hematopoietic Stem Cell Transplantation
06/2009 - 04/2006
1Organ Transplantation
01/2016
1Radiotherapy
12/2013
1Subcutaneous Injections
04/2012
1Drug Therapy (Chemotherapy)
01/2011
1Donor Selection
03/2009